Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients

Patricia Gordon, Janet A. Thomas, Ruth Suter, Elaina Jurecki

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences